VeriSign, Inc. (LON:0LOZ)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,871	15,887	16,509	18,076	20,822	18,086
Market Cap Growth	41.26%	-3.77%	-8.67%	-13.18%	15.12%	5.89%
Enterprise Value	19,773	16,811	17,180	18,748	21,257	18,558
Last Close Price	201.72	164.14	160.51	167.86	188.10	157.42
PE Ratio	32.34	25.31	25.72	32.32	35.92	30.30
PS Ratio	16.18	12.77	14.08	15.29	21.24	19.52
PB Ratio	-12.97	-10.16	-13.30	-13.94	-22.37	-17.76
P/FCF Ratio	-	22.74	26.03	27.10	37.38	35.95
P/OCF Ratio	-	22.04	24.63	26.21	34.93	33.82
EV/Sales Ratio	16.43	13.51	14.66	15.85	21.68	20.03
EV/EBITDA Ratio	23.44	19.22	20.95	22.82	31.47	29.10
EV/EBIT Ratio	24.20	19.89	21.87	23.95	33.21	30.74
EV/FCF Ratio	28.52	24.07	27.08	28.11	38.16	36.89
Debt / Equity Ratio	-0.90	-0.92	-1.14	-1.15	-1.42	-1.29
Debt / EBITDA Ratio	1.60	1.65	1.72	1.81	1.95	2.06
Debt / FCF Ratio	1.89	2.06	2.23	2.23	2.37	2.61
Asset Turnover	1.10	0.99	0.86	0.77	0.71	0.70
Quick Ratio	0.49	0.40	0.79	0.89	1.14	1.19
Current Ratio	0.54	0.43	0.83	0.93	1.18	1.23
Return on Assets (ROA)	46.56%	41.92%	35.92%	31.71%	28.89%	28.45%
Return on Capital (ROIC)	-	2200.91%	278.38%	155.01%	116.16%	145.71%
Return on Capital Employed (ROCE)	732.10%	-	178.50%	153.00%	95.30%	105.90%
Earnings Yield	3.09%	3.95%	3.89%	3.09%	2.78%	3.30%
FCF Yield	3.67%	4.40%	3.84%	3.69%	2.67%	2.78%
Buyback Yield / Dilution	5.68%	5.12%	4.17%	3.74%	2.69%	3.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.